Clinical Trial Update: Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating inhaled iloprost for disproportionate pulmonary hypertension in chronic obstructive pulmonary disease (COPD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• Iloprost (iloprost)

Snippet

Sponsor: Carmel Medical Center | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: UNKNOWN